Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Rituxan® (rituximab) – New orphan indication
June 7, 2018 - Genentech announced the FDA approval of Rituxan (rituximab) intravenous (IV) infusion, for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).
